Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 674 | 353 | 3,360 | 190 | 237 |
| Operating Income | -674 | -353 | -3,360 | -190 | -237 |
| Interest Expense | 107 | 29 | 28 | 29 | 19 |
| Other Income | -27 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -808 | -381 | -3,387 | -218 | -256 |
| Income Tax | -94 | N/A | N/A | N/A | 1 |
| Net Income Continuous | -714 | -381 | -3,387 | -218 | -257 |
| Minority Interests | -112 | N/A | N/A | N/A | N/A |
| Net Income | $-601 | $-381 | $-3,387 | $-218 | $-257 |
| EPS Basic Total Ops | -0.50 | N/A | -3.60 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | -0.62 | -0.33 | -2.85 | -0.18 | -0.22 |
| EPS Diluted Total Ops | -0.50 | N/A | -3.60 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | -0.62 | -0.33 | -2.85 | -0.18 | -0.22 |
| EBITDA(a) | $-663 | $-353 | $-3,360 | $-190 | $-237 |